ObsEva: ObsEva Files half Year 2023 Financial Statements
ObsEva SA, a biopharmaceutical company developing and commercializing novel therapies to improve women's reproductive health, published its Half Year 2023 Financial Statements.
Read full article »
ObsEva is a Switzerland-based biopharmaceutical company that develops novel therapeutics to improve women’s reproductive health and pregnancy.
Read more